Maryam Beigi, M.D.

Associate Director of the Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program

Mary S. Easton Center for Alzheimer's Research and Care at UCLA
Kagan Clinical Trials Program
710 Westwood Plaza, Room 1-123
Los Angeles, CA 90095-1769
Tel: (310) 794-6191
Fax: (310) 794-0540
Email: mbeigi@mednet.ucla.edu

Specialty

Neurology, Alzheimer's Disease, Dementia, and Memory Disorders.

Affiliations

Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program

Education and Degrees

M.D., Shiraz University (Former Pahlavi University), Shiraz, Iran

Internship, Shiraz University (Former Pahlavi University), Shiraz, Iran

Residency, Surgical and Clinical Pathology, Shiraz University (Former Pahlavi University), Shiraz, Iran

Fellowship, Immunopathology, University of Utah, Pathology Department, Salt Lake City, UT, USA

Internship, Internal Medicine, University of Utah, Medical Center, Salt Lake City, UT, USA

Residency, Adult and Child Neurology, UCLA-Kaiser Permanente, Los Angeles, CA, USA

Services

1990-1994 -- American Medical Association
1994-present -- American Academy of Neurology
2005-present -- California Society of Industrial Medicine

Publications

Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012;4(5):43. doi:10.1186/alzrt146 PMID: 23107780

"Peripheral lymph node-specific and payers patches-specific homing receptors are regulated following lymphocyte activation." Reg Immunol 1990;3(2):103-111. PMID: 2088474

"Dual effect of pertussis toxin on neutrophils in vivo. Pertussis toxin inhibits the extrvasation potential of mature neutrophils while stimulate granulopoiesis." Journal of Inflammation 1989;13(6):707-726. PMID: 2613295